ARTICLE | Clinical News
BLZ-100: Phase Ib started
October 20, 2014 7:00 AM UTC
Blaze began an open-label, dose-escalation, international Phase Ib trial to evaluate IV BLZ-100 in up to 21 patients with glioma undergoing surgery. BLZ-100 is also in Phase I testing in patients with...